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ABSTRACT Amyloid aggregates, found in patients that suffer fromAlzheimer’s disease, are composed of ﬁbril-forming peptides
in ab-sheet conformation. One of themost abundant components in amyloid aggregates is theb-amyloid peptide 1–42 (Ab 1–42).
Membrane alterations may proceed to cell death by either an oxidative stress mechanism, caused by the peptide and synergized
by transition metal ions, or through formation of ion channels by peptide interfacial self-aggregation. Here we demonstrate that
Langmuir ﬁlms of Ab 1–42, either in pure form or mixed with lipids, develop stable monomolecular arrays with a high surface
stability. By using micropipette aspiration technique and confocal microscopy we show that Ab 1–42 induces a strong membrane
destabilization in giant unilamellar vesicles composed of palmitoyloleoyl-phosphatidylcholine, sphingomyelin, and cholesterol,
lowering the critical tension of vesicle rupture. Additionally, Ab 1–42 triggers the induction of a sequential leakage of low- and high-
molecular-weight markers trapped inside the giant unilamellar vesicles, but preserving the vesicle shape. Consequently, the Ab
1–42 sequence confers particular molecular properties to the peptide that, in turn, inﬂuence supramolecular properties associated
tomembranes thatmay result in toxicity, including: 1), an ability of the peptide to strongly associatewith themembrane; 2), a reduc-
tion of lateral membrane cohesive forces; and 3), a capacity to break the transbilayer gradient and puncture sealed vesicles.
INTRODUCTION
Alzheimer’s disease is characterized by the presence of
amyloid plaques surrounded by dead and damaged neurons in
the brain (Selkoe, 1991; Matsuzaki and Horikiri, 1999). One
of the most abundant components of these plaques is the
b-amyloid peptide 1–42 (Ab 1–42). This peptide is the prod-
uct of the proteolytic cleavage of the Amyloid Precursor Pro-
tein (Kang et al., 1987; Selkoe, 1993). In the core of the plaque
the amyloid peptides adopt an antiparallel b-sheet conforma-
tion (McLaurin et al., 1998). Ab 1–42 is toxic to neuronal
cells in culture when they are exposed to the aggregated form
of the peptide (Yankner et al., 1990; Lambert et al., 1998).
Although the etiologic role of amyloid peptide (Ab 1–42) in
Alzheimer’s disease is accepted (Kang et al., 1987; Selkoe,
1993), the molecular mechanism of neurotoxicity remains
unclear and is under debate.
Anumber of observations indicate that the primary target of
amyloid peptides is the cell membrane of neurons. It was
previously reported that amyloid peptides alter important
physical and biological properties of these membranes
(Arispe et al., 1993; Pillot et al., 1996; Choo-Smith et al.,
1997) and interact with speciﬁc lipids (Terzi et al., 1997; Ji
et al., 2002a,b; Curtain et al., 2003; Lau et al., 2003). In
addition, several studies reported in the last few years
demonstrate that Alzheimer’s peptides form ion pores in
membrane bilayers (Lin et al., 2001; Kagan et al., 2002;
Arispe, 2004; Micelli et al., 2004). Important membrane-
peptide interactions, including peptide insertion, cytotoxicity,
and pore formation, have been described when cholesterol is
present in model membranes and correlated with the presence
of transient lipid domains or lipid rafts (Arispe andDoh, 2002;
Ji et al., 2002b; Curtain et al., 2003; Lau et al., 2003; Tashima
et al., 2004). Sphingomyelin-cholesterol (SM/Chol) lipid
bilayers are known to form rafts or liquid-ordered/liquid-
disordered domains that are representative of a native cellular
membrane (Dietrich et al., 2001). Recently, cholesterol (Chol)
was associated with the membrane release of b-amyloid pep-
tide from brain lipid bilayers (Tashima et al., 2004).
In this work, we have analyzed the surface properties and
lipid-peptide interactions of Ab 1–42 using the monolayer
technique. By micropipette aspiration we have quantitatively
measured a membrane destabilization effect when giant
unilamellar vesicles (GUVs) are exposed to Ab 1–42 peptide.
Also, we have developed a new method using confocal
microscopy to directly observe the lytic or membrane-
disruptive action of peptides. This new approach employs
GUVs ﬁlled with different molecular size ﬂuorophores and
allows us to monitor membrane integrity and vesicle leakage
after peptide addition to the freestanding membranes.
The data reported in our study demonstrate that: 1), Ab
1–42 forms highly stable ﬁlms at the air-water interface; 2),
the behavior of peptide-lipid monolayers depends on the lipid
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composition; 3), the presence of Ab 1–42 peptide desta-
bilizes lipid bilayers, as indicated by a reduction of the
critical lysis tension of GUVs; and 4), the peptide strongly
alters the permeability of bilayers in GUVs, followed by the
leakage of the ﬂuorescent contents. The results support the
idea that the destructive action of toxic accumulated Ab
1–42 peptide over neurons may primarily be originated by
an irreversible damage at the cell membrane level.
MATERIALS AND METHODS
Chemicals
1,2-di-palmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), cholesterol (Chol), and
bovine brain sphingomyelin (SM) were purchased from Avanti Polar Lipids
(Birmingham, AL) and used without further puriﬁcation. Alexa488-dextran
and Alexa546-maleimide were obtained from Molecular Probes (Eugene,
OR).
Ab 1–42 was prepared by continuous ﬂow Fmoc-solid phase peptide
synthesis as previously described (Tickler et al., 2001). After global cleav-
age and deprotection in a mixture of triﬂuoroacetic acid/H2O/ethanedithiol/
triethylsilane (94:2.5:2.5:1 v/v, 10 ml), the crude lyophilized Ab 1–42 (;20
mg) was then dissolved in 0.1% aq. triﬂuoroacetic acid solution (10 ml) and
1 ml aliquots were reacted with hydrogen peroxide (250 mL) for 10 min at
room temperature, then immediately puriﬁed by RP-HPLC and lyophilized.
Analysis by matrix-assisted laser desorption ionization time of ﬂight mass
spectrometry MH1 found 4517 (expected 4515), and amino-acid analysis
showed good correlation with expected values.
Monolayer studies
Monolayer experiments were performed at room temperature. The subphase
was NaCl 145 mM at the speciﬁed pH. Pure peptide monolayers were
formed by direct spreading from DMSO/chloroform/methanol (50:33:17,
v/v) solutions by using a microsyringe. The total surface area of the Teﬂon
trough was 80 cm2 with a 75-ml volume of the subphase. Spreading solvent
was allowed to evaporate for at least 5 min before compression was started,
at a rate of 43 cm2/min. For lipid-peptide mixed monolayers, peptide and
lipid were premixed in the desired proportions from their respective pure
solution, and then directly spread on the surface. The surface pressure (P,
Wilhelmy method via platinized-Pt plate), the area enclosing the monolayer,
and the surface potential (DV, via milliVoltmeter with air-ionizing 241Am
plate and calomel-electrode pair) were automatically measured (with the con-
trol unit Monoﬁlmmeter with Film Lift, Mayer Feintechnique, Gottingen,
Germany). The data were continuously and simultaneously recorded with
a double-channel X-YY recorder.
The calculation of the expected cross-sectional molecular area of an
a-helix parallel or perpendicular to the air-water interface can be calculated
assuming an ideal all-a-helix conformation. The peptide length is estimated
considering an average of 0.15 nm of axial rise per residue for an a-helix
structure. A diameter of an ideal a-helix with hydrophobic amino acids is
estimated in 1.5 nm—0.5 nm for the helix backbone and 1.0 nm for the
lateral side chains of the amino acid surrounding the helix backbone
(Ambroggio et al., 2004).
The behavior of mixed lipid-peptide monolayers was analyzed by
comparing the experimental force-area curve with the theoretical isotherm
for the corresponding ﬁlms in which no interactions between the ﬁlm-
forming molecules are assumed (Gaines, 1966; Fidelio et al., 1981). The
immiscible behavior between the ﬁlm-forming molecules in the mixed
monolayer was determined according to the surface phase rule (Gaines,
1966; Fidelio et al., 1981). The collapse pressure is the highest lateral
pressure by which a monolayer can be compressed without detectable
expulsion of the molecules to form a bulk phase (Gaines, 1966). In practice,
the collapse pressure of a compression isotherm is taken at the point of
surface pressure where we observe the ﬁrst discontinuity in the lateral
pressure-area isotherm. This was estimated by taking the tangent of each
point (derivative) of the curve. Brieﬂy, if one collapse point is observed for
a mixed ﬁlm (in which individual components have differentiated collapse
pressures) the surface phase rule determines lateral miscibility in the ﬁlm.
Conversely, if two collapse points are well determined in the isotherm,
a lateral inhomogeneity (with some ﬁlm-forming amphiphile molecules
separating out from the rest of ﬁlm components when they are under
compression) is expected (Gaines, 1966).
Vesicle preparation, confocal microscopy, and
micropipette aspiration techniques
For confocal microscopy experiments, phospholipid stock solutions were
prepared in chloroform at concentrations of 0.2 mg/ml. In our experiments
we formed giant unilamellar vesicles (GUVs) with POPC and POPC/SM/
Chol (1:1:1 molar ratio).
The electroformation method, developed by Angelova and co-workers
(Angelova and Dimitrov, 1986; Angelova et al., 1992) was used to prepare
giant vesicles. GUVs were formed in a temperature-controlled chamber as
described previously (Bagatolli and Gratton, 1999, 2000). GUVs were
prepared using the following steps: 3 ml of lipid stock solution were spread
on each of the two sample chamber platinum wires. The chamber was then
put into a vacuum overnight to remove any remaining trace of organic
solvent. The chamber and a solution of sucrose 150 mM, Alexa488-Dextran
1 mM, and Alexa546-maleimide 10 mM with an overall osmolarity of 150
mOsM (measured with an Advanced Instruments Model 3D3 Osmometer;
Advanced Instruments, Norwood, MA) were separately equilibrated to
temperatures above the lipid mixture phase transition(s) and then 0.4 ml of
sucrose solution containing the ﬂuorophores was added to cover the
platinum wires. Immediately after buffer addition, the platinum wires were
connected to a function generator (Digimess FG 100; Grundig Instruments,
Nurnberg, Germany) and a low-frequency alternating ﬁeld (sinusoidal wave
function with a frequency of 10 Hz and amplitude of 1 V) was applied for
120 min. The AC ﬁeld was turned off and the GUVs were collected from the
chamber. To remove nontrapped ﬂuorescent probes, the vesicles were
washed several times with iso-osmolar glucose solution, leaving the sucrose-
dye-loaded GUVs (higher density) to precipitate at the bottom of a 15-ml
centrifuge tube and then discarding the supernatant.
Aliquots of giant vesicles suspended in glucose (0.3 ml) were added to an
eight-well plastic chamber (Lab-Tek Brand Products, Naperville, IL). Due to
the density difference between the sugar solutions inside and outside of
vesicles, GUVs precipitate at the bottom of the chamber, which facilitates
the observation in the inverted confocal microscope. The chamber was
located in an inverted confocal microscope (Zeiss LSM 510 META; Carl
Zeiss, Jena, Germany) for observation. The excitation wavelengths were
488 nm (for Alexa488-Dextran) and 543 nm (for Alexa546). An iso-osmolar
solution of peptide then was injected into the chamber and a time-series scan
was started to follow the peptide-vesicle interaction.
All leakage experiments where quantitatively analyzed by using
MetaMorph software (Universal Imaging, Molecular Devices, Downing-
town, PA) by measuring the change in ﬂuorescence intensity for each probe
inside the GUVs after exposure to Ab 1–42 peptide.
The micropipette technique allows the direct physical manipulation of
individual GUVs and the controlled application of mechanical stresses to the
lipid bilayer; in this manner, material properties of the bilayer such as the
critical lysis tension can be measured (Evans and Needham, 1987; Evans and
Rawicz, 1990). Sucrose-ﬁlled vesicles were diluted in an iso-osmolar glu-
cose solution and added to a custom-designed micromanipulation chamber
(chamber A, volume;400 ml) pretreated with bovine serum albumin (BSA,
1 mg/ml) to prevent lipid adhesion to the glass (before the addition of GUVs
and peptide solution, the BSA was ﬂushed out of the chamber several times
with BSA-free glucose solution). A small aliquot (;1–2 ml) of vesicle
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suspension were added to the glucose-ﬁlled chamber, and after a few
minutes the vesicles precipitated at the bottom of the chamber. The chamber
was mounted on the modiﬁed stage of a Zeiss Axiovert S100 inverted
microscope, and the vesicles were observed with Hoffman Modulation
Contrast optics (403 objective magniﬁcation, 1003 total magniﬁcation; W.
Nuhsbaum Inc., McHenry, IL). The micropipette was connected to a water-
ﬁlled manometer with in-line pressure transducers (Validyne Engineering,
Los Angeles, CA) that allowed accurate measurements of applied suction
pressures at the pipette tip. All experiments were continuously recorded to
video and analyzed separately. Initially, as a control, a test vesicle was
aspirated using a 5-mm diameter micropipette and the suction pressure was
steadily increased until the vesicle lysed. The lysis tension (tlyse) was then
calculated using the relation below (Evans and Needham, 1987),
tlyse ¼ Rpip
2ð1 Rpip=RvesÞDP; (1)
where DP is the suction pressure applied, and Rpip and Rves are the pipette
inner radius and vesicle spherical radius, respectively.
After the control, vesicles of the appropriate size and unilamellarity were
selected, gently aspirated at a sublytic level of applied tension, and trans-
ferred to an adjacent test chamber containing peptide in equiosmotic glucose
solution (chamber B). The transfer was effected by inserting the vesicle (and
the micropipette supporting it) inside the bore of a large (;100–200 mm)
transfer pipette, ﬁlled with glucose solution, which acted as a protective
sheath for the vesicle during transfer from one chamber to another. The
vesicle was held under a constant suction pressure. If peptides interact and
destabilize the membrane by insertion, then a membrane projection into the
micropipette may be seen and a new tlyse can be calculated.
The peptide solutions were prepared by dilution of Ab 1–42 from
a concentrated DMSO solution to a glucose solution. The ﬁnal osmolarity of
the sample was measured and adjusted to the same values as for the vesicle
and chamber solutions, to prevent unwanted water efﬂux or inﬂux through
the bilayer from occurring during the experiment.
The experiments were carried out at room temperature. At this
temperature GUVs composed of POPC/SM/Chol (1:1:1 molar ratio) display
liquid ordered-liquid disordered phase coexistence (not shown) as pre-
viously reported for DOPC/SM/Chol (1:1:1 molar ratio) mixtures (Dietrich
et al., 2001).
RESULTS
Pure peptide monolayers
Pure Ab 1–42 monolayers show a collapse pressure (stability
of the ﬁlm against lateral compression) of ;33 mN/m,
a surface potential at maximal packing (at collapse pressure)
of ;260 mV and a molecular area of 2.30 nm2/molecule,
deduced from the compression isotherms of the ﬁlm (Fig. 1).
Lipid-peptide mixed monolayers
The compression isotherms of Ab 1–42 mixed with DPPC at
different peptide-lipid area ratios are shown in Fig. 2. A
surface molecular area analysis is necessary because the area
of Ab 1–42 is more than three times higher than the
corresponding molecular area of the lipids, and equimolar
proportions of both components will generate ﬁlms in which
80% of the surface area is covered by the peptide. Two
collapse pressures can be seen in the compression isotherms
of Ab 1–42-DPPC mixed monolayer (Fig. 2). The lower
collapse pressure (from 30 to 40 mN/m) is indicative of the
collapse of the peptide-enriched phase. On the other hand,
the higher collapse pressure (;60 mN/m) indicates the
collapse of the lipid-enriched phase (Gaines, 1966; Am-
broggio et al., 2004). When the proportion of the peptide was
lowered in the mixed interface, the lower collapse pressure
went up, indicating a partial miscibility of the peptide with
the lipid.
DPPC has a liquid-expanded to liquid-condensed phase-
transition at ;10 mN/m, as is observed in Fig. 2 (Gaines,
1966). This transition is still present when the lipid was
mixed with Ab 1–42 but it becomes more distorted as the
peptide proportion is increased (Fig. 2). At low proportion of
peptide, slightly positive deviations from the ideal mixing
behavior were observed (,10%; not shown).
A similar behavior was seen in POPC-Ab 1–42 mixed
interfaces. Pure POPC monolayers are liquid-expanded. A
FIGURE 1 Surface behavior of pure Ab 1–42 peptide monolayers.
Lateral pressure area (solid line) and surface potential area (dashed line)
isotherms of Ab 1–42. The subphase was 145 mM NaCl, pH 6.
FIGURE 2 Surface behavior in mixed DPPC-Ab 1–42 peptide interfaces.
Lateral pressure area (solid line) and surface potential area (dashed line)
isotherms. The corresponding peptide area as a proportion of the mixed
monolayer was 25% (1), 50% (2), and 75% (3). Subphase 145 mM NaCl,
pH 6. Arrows indicate the collapse pressure of the peptide-enriched phase.
Note the effect of the peptide on the liquid expanded-liquid condensed
phase transition of the DPPC-enriched phase (;10 mN/m).
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partial miscibility of the peptide was deduced and no obvious
deviations from ideal behavior were observed (not shown).
Also, a partial miscibility is evidenced, since the ﬁrst collaps-
ing point is increased as the peptide proportion is lowered
in the mixed interface.
Compression isotherms for Ab 1–42 mixed with POPC/
Chol (7:3 molar ratio), SM, SM/Chol (7:3 molar ratio), and
POPC/SM/Chol (1:1:1 molar ratio) were analyzed. The
collapse pressure of the peptide-enriched phase depends on
the lipid composition (Table 1) and was in the range of
between 32 and 43 mN/m when it was analyzed at the same
lipid/peptide area proportion. Slight deviations from ideal
behavior were observed at the lipid/peptide proportions
studied.
Micropipette manipulation
Videomicrographs of vesicles composed of POPC and
POPC/SM/Chol (1:1:1 molar ratio) are shown in Fig. 3
(top and bottom, respectively). Vesicle diameters were in the
range of 25–35 mm. A suction pressure was applied to the
vesicles with a micropipette and the critical tension of lysis
(tlyse) was measured for vesicles exposed to an Ab 1–42
peptide solution. These critical tension values were com-
pared with those obtained for GUVs without peptide expo-
sition (Fig. 3).
Pure POPC vesicles had a tlyse of;8.26 0.1 mN/m (Fig.
3 A, top); after peptide exposure this pressure decreased
drastically to 0.3 mN/m (Fig. 3 B, top). A signiﬁcant feature
was the loss of the optical contrast between the sucrose
solution inside of the vesicle and the glucose solution outside
of the vesicle; this change in appearance indicates that the
bilayer becomes leaky, and the mixing of the two sugar so-
lutions occurs.
Vesicles composed of POPC/SM/Chol (1:1:1 molar ratio)
had a higher tlyse than POPC vesicles (Fig. 3 A, bottom). The
average tlyse was 126 1 mN/m. The higher value relative to
pure POPC bilayers is consistent with the known effect of
cholesterol on the mechanical properties of ﬂuid phase
bilayer vesicles (Needham and Nunn, 1990). When the
POPC/SM/Chol vesicles were exposed to 5 mM solution of
Ab 1–42, the critical tension of lysis was lower, falling to
4 mN/m, and a membrane projection into the micropipette is
observed (Fig. 3 B, bottom). A loss of the sucrose-glucose
phase contrast was also visually observed (as it was previ-
ously indicated for pure POPC system; not quite well appreci-
ated from Fig. 3).
For both POPC and POPC/SM/Chol, there was a lag time
in the peptide-vesicle interaction of ;10 s after vesicle ex-
posure to Ab 1–42. This time is the time elapsed before any
perceptible change in tension can be measured after peptide
exposure.
Confocal microscopy
The incorporation of both ﬂuorophores Alexa488-Dextran
(MW 10,000) and Alexa546-maleimide (MW ;1300) inside
of GUVs is useful to directly observe any effect on mem-
brane permeability in a continuousmanner (leakage of probes
from the vesicles).
Fig. 4 (top) shows a time-series after addition of amyloid
peptide into the chamber containing POPC GUVs. Initially
we observed some lysis of vesicles, although a high popu-
lation of POPC GUVs remained ﬁlled with the probes. After
50 s the loss of the small Alexa546-maleimide ﬂuorophore
(red) was evident from the images. This last event occurs
without signiﬁcant leakage of the high molecular weight
probe (Alexa488-dextran ﬂuorophore, green). A similar effect
was observed when GUVs composed of POPC/SM/Chol
(1:1:1 molar ratio) loaded with both ﬂuorophores were
exposed to Ab 1–42 (Fig. 4 bottom). It is noteworthy that the
TABLE 1 Collapse pressure of the Ab 1–42 enriched phase in
lipid-peptide monolayers
Lipid (molar ratio)
Collapse pressure
(mN/m)*
DPPC 34
POPC 35
POPC/Chol (7:3) 33
SM 43
SM/Chol (7:3) 39
SM/POPC/Chol (1:1:1) 32
*Standard deviation: 61 mN/m.
FIGURE 3 Videomicrographs of GUVs tested by micromanipulation
after exposure to Ab 1–42 peptide. Giant unilamellar vesicle composed of
POPC (top) and composed of POPC/SM/Chol (1:1:1 molar ratio, bottom)
held under constant, low membrane tension exposed to 5 mM Ab 1–42
peptide. (A) Before and (B) after peptide exposure. tlyse is the critical tension
to lyse the vesicle (mN/m) and is shown in the ﬁgure to denote the change
in the membrane physical properties under the different conditions. It is the
average tension when the vesicle breaks as the suction pressure was
increased. Videomicrographs were taken optimizing the brightness and
contrast setup to set the best condition for vesicle vision. The size bar at
bottom-right of each panel indicates the scale of the pictures (5 mm). Inserted
bars indicate the diameter of GUVs and the projection toward the inner of the
suction pipette after peptide interaction.
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GUVs containing cholesterol display some budding process
in the absence of peptide in agreement with that reported by
Baumgart and co-workers for DOPC/SM/Chol mixtures
(Baumgart et al., 2003).
The different permeation rates of the two ﬂuorophores are
shown in Fig. 5 (A and B). The small ﬂuorophore is ﬁrstly
released from inside of the vesicles before the loss of the high
molecular weight ﬂuorophore. Fig. 5 also shows no signif-
icant changes in ﬂuorescence intensity in absence of the
peptide (Fig. 5 A, inset). This last observation supports the
fact that the probes do not undergo signiﬁcant photo-
bleaching under our experimental conditions. Therefore, we
corroborate that the observed decrease in ﬂuorescence
intensity is due to the leakage of the probe(s).
These results are also supported by the loss of the sucrose-
glucose phase contrast observed in the micropipette aspi-
ration experiments (see above) and denote a considerable
modiﬁcation in the permeability properties of a GUV’s mem-
brane.
DISCUSSION
In this report we have shown that amyloid Ab 1–42 peptide
forms insoluble monolayers with high stability against lateral
compression, where the collapse pressure for pure peptide
ﬁlms was;33 mN/m (Fig. 1). This high stability is in agree-
ment with a peptide monolayer at the air-water interface
where the peptidemolecules adoptsmainly ab-sheet structure
(Fidelio et al., 1986a; Maget-Dana et al., 1999; Maget-Dana,
1999). Schladitz et al. (1999) clearly showed that the main
secondary structure of Ab 1–40 peptide (two amino acids
,Ab 1–42 at the carboxyl-terminus) is an antiparallelb-sheet
FIGURE 4 Direct visualization of lytic action of Ab 1–42 peptide.
Confocal microscopy of POPC (top) and POPC/SM/Chol (1:1:1 molar ratio,
bottom) GUVs, ﬁlled with Alexa488-Dextran (green) and Alexa546-
Maleimide (red), exposed to Ab 1–42 7.5 mM. Effect of lipid-peptide
interaction from the time, 0 s: injection of the peptide. Arrows indicate the
differential leakage of the ﬂuorophores.
FIGURE 5 Dye release kinetics from inside GUVs after Ab 1–42 peptide
exposure. Alexa488-Dextran (squares) and Alexa546-Maleimide (circles)
leakage from inside POPC (A) and POPC/SM/Chol (1:1:1 molar ratio) (B)
GUVs after exposure to Ab 1–42 7.5 mM. The ﬂuorescence intensity was
measured with MetaMorph software by quantifying the average gray value
of Alexa488-Dextran and Alexa546-Maleimide of each picture inside the
GUVs after exposition to Ab 1–42 peptide. (A, inset) Alexa488-Dextran
(squares) and Alexa546-Maleimide (circles) ﬂuorescence intensity in
absence of peptide (see text). Initial rates of leakage (slope of the initial
linear behavior of dye leakage after peptide exposure): (A) Alexa488-
Dextran: 0.72 AU/s, Alexa546-Maleimide: 1.45 AU/s; and (B) Alexa488-
Dextran: 0.52 AU/s, Alexa546-Maleimide: 0.96 AU/s.
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parallel to the air-water interface and part of the sequence is
an a-helix perpendicular to the interface in a pure peptide
monolayer set at 13mN/m of surface lateral pressure.We ﬁnd
that Ab 1–42 peptide has a molecular area of ;2.3 nm2/
molecule (at maximal packing, 33 mN/m). This cross-
sectional molecular area observed for the peptide is greater
than that theoretically expected for the entire sequence of the
peptide adopting an a-helix conformation perpendicular to
the interface (;1.8 nm2, see Materials and Methods) and, for
this reason, it can be reasonably speculated that a mixture of
conformation and orientation for the peptide is possible
(Fidelio et al., 1981, 1986b; Ambroggio et al., 2004).
Furthermore, the high collapse pressure and the low surface
potential observed for the amyloid peptide monolayer are in
keeping with peptides adopting b-sheet structure at the
interface (Fidelio et al., 1986a; Maget-Dana at al., 1999;
Ambroggio et al., 2004). These data also support that Ab
1–42 instead adopts amore complex conformation (mixture of
secondary structures at the air-water interface) at the interface.
The results from lipid-peptide mixed ﬁlms indicated that
Ab 1–42 peptide has partial miscibility behavior with the
lipids employed. The lateral stability of the mixed interface
before the peptide-enriched phase collapses was in the range
described previously for biological membranes (Blume,
1979; Seelig, 1987). This behavior suggests that the peptide
interacts with the membrane, becoming part of it. This means
that the peptide remains in the lipid environment at lateral
pressures compatible with natural membranes. The fact that
no signiﬁcant deviations from the ideal mixing behavior are
observed in the peptide-lipid monolayer data, led us to
consider that the presence of the peptide at themembranemay
promote local damage to the lipid interface, altering such
supramolecular physical properties as the cohesive forces and
membrane permeability.
Another important contribution of this work is the direct
analysis of the stability of model membranes, represented by
giant unilamellar vesicles, which have been exposed to Ab
1–42 peptide solution. In the micropipette manipulation
experiments (Fig. 3) the effects of peptide exposure were
clearly demonstrated. The results showed that Ab 1–42
peptide disrupts the membrane of GUVs composed of POPC
or POPC/SM/Chol. These data demonstrate membrane
destabilization resulting from the lipid-peptide interaction,
where the critical lysis tension of the vesicles was reduced
(for POPC GUVs, tlyse goes from 8.2 to 0.3 mN/m and for
POPC/SM/Chol GUVs, tlyse goes from 12 to 4 mN/m),
indicating the loss of cohesion between the membrane
components—a feature that has not been quantitatively
described for Ab 1–42 previously. Notably this reduction in
the critical lysis tension is seen for both POPC bilayers and
those with SM/Chol, which better resemble a natural
membrane. As mentioned before, when the vesicles were
exposed to Ab 1–42 peptide there was a lag time for action,
and the interaction takes place with a loss in the sucrose-
glucose phase contrast and a reduction of the cohesive
forces. The loss in the phase contrast can be explained by an
alteration in the permeability of the membrane due to the
protein-lipid interaction. The permeation of the sucrose from
inside the vesicles (or the penetration of glucose into the
GUVs) could be a result of pore-like structures formed in the
membrane. These results are analogous to those reported by
Longo et al. (1998) for melittin, a lytic pore-forming peptide,
which signiﬁcantly weakens PC vesicles to yield tlyse with
similar values to those obtained in our experiments.
The micropipette results discussed above are in agreement
with the data obtained from confocal microscopy. GUVs
loaded with two ﬂuorescent probes differing in their molec-
ular sizes have given us the possibility of a direct visuali-
zation of the differential leakage when the permeability of
the membrane is altered as a consequence of amyloid peptide
interaction. Several vesicles were analyzed and, as observed
in the micropipette aspiration experiments, the stability of
POPC and POPC/SM/Chol GUVs was greatly altered when
they were exposed to Ab 1–42 peptide. Our results showed
the lysis of ﬂuorescent-labeled vesicles and differential
leakage of the probes when the peptide interacts with the
membrane (as well as the loss of the sucrose-glucose phase
contrast). The fast loss of the small ﬂuorescence probe and
the progressive loss of the larger one from inside of the
vesicles without a membrane solubilization effect due to
peptide-membrane interaction led us to infer that the amyloid
peptide may induce singular lipid-peptide organization
allowing, in turn, a differential leakage property at the mem-
brane. The effect of amyloid peptide was seen in vesicles of
different composition, although some differences were seen
between POPC liposomes compared with those formed by
SM/Chol, with somewhat slower rate of dye release for the
latter (see legend of Fig. 5). Our results suggest that Ab 1–42
peptide induces release of ﬂuorescent dye of characteristic
size, in agreement with the leakage behavior reported by
Pillot and co-workers where small unilamellar vesicles
loaded with Calcein were exposed to fragments of Ab 1–42
peptide (Pillot et al., 1996). Furthermore, using atomic force
microscopy, Lin and co-workers have shown that Ab 1–42
forms hexameric structures in model membranes (Lin et al.,
1999, 2001), which would be in accordance with our data.
In summary, our results indicate that amyloid peptide
clearly disrupts membrane bilayers. Ab 1–42 peptide has
high surface activity similar to that reported for naturally
occurring phospholipids with a liquid-expanded characteris-
tic. The stability and miscibility of the peptide monolayer
depends on the type of lipids at the interface. The peptide
directly interacts with the lipids, associating with the mem-
brane and altering its mechanical properties by changing the
cohesive properties among membrane components and the
permeability of the bilayer. Mixed lipid-peptide monolayers
conﬁrm the ability of the amyloid peptide to support lateral
pressures found in natural membranes. Clearly the peptide-
lipid interaction induces changes in membrane permeability
and this fact could be a consequence of Ab 1–42 peptide
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formation of leaky peptide-lipid supramolecular structures at
themembrane. It is noteworthy to emphasize that theAb 1–42
amyloid peptide has some particular characteristics in com-
mon with other amphipathic peptides: an ability to remain at
the interface (high lateral stability), with a marked trans-
bilayer instability effect (measured by its capacity to provoke
leakage). A similar behavior was observed for antibiotic
peptides isolated from Australian tree frog (Ambroggio et al.,
2004). An additional important detail is that the effect was
observed with Ab 1–42 in its soluble form, which may have
physiological implications in damaging neuronal membranes
and Alzheimer’s disease.
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